TrialPath
← Back to searchRecruiting

Device Use Reimagined Through Education And Mentorship

NCT06546930 · University of California, San Francisco
In plain English

Click the button to translate this study into plain language — what it is, who qualifies, and what participation looks like.

Official title
Optimizing Diabetes Technology Use for Latinx Youth Through DREAM (Device Use Reimagined Through Education And Mentorship) Virtual Peer Groups [Study-wide] - DREAM Intervention
About this study
This multi-site project has two phases: phase 1 involved stakeholders focus groups to assess barriers and facilitators to diabetes technology and the creation of advisory councils. Feedback was obtained and used to develop phase 2, the single arm trial. A virtual peer group curriculum is being refined and will be implemented. The aims of this project are: (1) Partner with stakeholders to design a virtual peer group (VPG) intervention to promote the initiation and continued use of diabetes technology among Latinx adolescents with T1D. (2) Evaluate the feasibility and acceptability of DREAM VPGs in a pragmatic, single arm trial. (3) Assess the effects of DREAM VPGs on clinical and person-centered outcomes. Our DREAM intervention will: * Build trust/rapport and "relational connections" between participants * Empower participants to be advocates in their/their adolescents' diabetes care * Provide tools/knowledge to navigate healthcare and diabetes technology systems * Increase knowledge, confidence, and interest in using diabetes technology * Create a culturally sensitive/inclusive VPG toolkit that will be scalable, feasible, and sustainable in broader clinical contexts if found to be beneficial The DREAM project's findings will inform future efforts to improve diabetes technology use and T1D health outcomes among Latinx adolescents. If found to be effective, the VPG curriculum can be adapted for other clinic settings in order to improve education and peer support for Latinx patients and families. Future studies may extend or adapt DREAM to other cohorts, including other age groups, geographic settings, or marginalized and historically excluded populations with T1D.
Eligibility criteria
Inclusion Criteria: * Adolescents 13-17 years old and their caregivers * Adolescent must have T1D of any duration, and be receiving diabetes care at UCSF, CHLA or UC Davis * Self-identify as Latina/o/x or other variations such as Hispanic * Preferred language of English or Spanish Exclusion Criteria: * Participants who have a medical, developmental, or psychiatric condition that would make peer group participation difficult * Adolescents who are planning to transfer care to a different medical center within the next year, which would prevent assessment of longitudinal outcomes
Study design
Enrollment target: 120 participants
Allocation: non_randomized
Masking: none
Age groups: child
Timeline
Starts: 2024-10-11
Estimated completion: 2026-05-31
Last updated: 2025-10-15
Interventions
Behavioral: DREAM intervention
Primary outcomes
  • Caregiver Survey (Baseline)
  • Caregiver Phase 2 Intervention Survey - "Feedback Survey" (End of Study to (6-15 months))
  • Caregiver In Person Event Evaluation (Throughout the study, up to 15 months)
Sponsor
University of California, San Francisco · other
With: Children's Hospital Los Angeles, University of California, Davis, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Contacts & investigators
ContactCristina Acosta Navarro, BA · contact · cristina.acostanavarro@ucsf.edu · 628-224-8436
ContactJenise C Wong, MD, PhD · contact · Jenise.Wong@ucsf.edu · 415-476-3316
InvestigatorJenise C Wong, MD, PhD · principal_investigator, University of California, San Francisco
All locations (3)
University of California, DavisRecruiting
Davis, California, United States
Children's Hospital Los AngelesRecruiting
Los Angeles, California, United States
University of California, San FranciscoRecruiting
San Francisco, California, United States